Abbott Labs Beats, Raises Guidance and Dividend

HFA Padded
HFA Staff
Published on
Updated on

Abbott Laboratories (NYSE:ABT) released its earnings report for the three months ended September 30 this afternoon before the market opened on Wall Street. The company showed earnings of $0.55 on revenue of $5.369 billion. Shares in the health care company closed at $3.71 on Tuesday’s market. In the lead up to the release of the Abbot Laboratories (NYSE:ABT) earnings report analysts studying Abbott Laboratories (NYSE:ABT) were looking for earnings of 52 cents per share from the company. Revenue was expected to come in at $5.4 billion. In the same three months of last year the company earned $1.30 per share….

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

The post above is drafted by the collaboration of the Hedge Fund Alpha Team.